| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 532.607 | - | - | 3.040 | 75 | 2.904 | 773 | 7.660 | 0 | 0 |
| Total Expenses - EUR | 540.242 | - | - | 3.328 | 3.452 | 18.276 | 4.762 | 7.838 | 183 | 842 |
| Gross Profit/Loss - EUR | -7.635 | - | - | -288 | -3.377 | -15.373 | -3.989 | -178 | -183 | -842 |
| Net Profit/Loss - EUR | -7.635 | - | - | -288 | -3.377 | -15.373 | -3.989 | -178 | -183 | -842 |
| Employees | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Transmed Pro S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 35.002 | - | - | 33.434 | 32.787 | 17.319 | 16.935 | 16.987 | 16.936 | 16.841 |
| Current Assets | 510.724 | - | - | 402.882 | 395.090 | 382.040 | 378.384 | 379.353 | 378.015 | 375.264 |
| Inventories | 54.900 | - | - | 19.340 | 18.966 | 18.606 | 27.274 | 27.359 | 27.276 | 27.124 |
| Receivables | 217.053 | - | - | 376.963 | 369.663 | 357.797 | 283.022 | 341.083 | 345.277 | 342.785 |
| Cash | 238.469 | - | - | 6.289 | 6.177 | 5.359 | 67.816 | 10.637 | 5.190 | 5.085 |
| Shareholders Funds | -253.165 | - | - | -247.435 | -246.020 | -265.352 | -263.456 | -264.452 | -263.833 | -263.200 |
| Social Capital | 281 | - | - | 269 | 263 | 258 | 253 | 253 | 253 | 251 |
| Debts | 801.163 | - | - | 685.920 | 676.024 | 664.711 | 658.775 | 660.791 | 658.784 | 655.305 |
| Income in Advance | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4399
|
|||||||||
Comments - Transmed Pro S.r.l.